Drug intelligence / Profile preview

Immunitor

Development stage
Preclinical
Lead developer
Immunitor
Modality
Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

**Immunitor** is a non-specific name used for a family of orally administered therapeutic vaccine products developed by Immunitor. In the provided context, it refers not to one single molecular entity but to several distinct oral tableted biologic immunotherapies, including V-1 for HIV/AIDS, V-5 for hepatitis B, hepatitis C, tuberculosis, and hepatocellular carcinoma-related development, and V7 for tuberculosis. These products are described as oral therapeutic vaccines based on inactivated or pooled pathogen-derived antigens, designed to stimulate mucosal and innate immune responses rather than acting through a single well-defined receptor target. Because the exact active composition, pathogen content, and indication vary by product, \"Immunitor\" should be treated as an umbrella product name rather than a uniquely identifiable drug substance.

Other names
Immunitor

Beyond the preview

Go deeper on Immunitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunitor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call